Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic vaccines for cancer: an overview of clinical trials.
Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C, Faulkner I, Mellstedt H. Melero I, et al. Among authors: gaudernack g. Nat Rev Clin Oncol. 2014 Sep;11(9):509-24. doi: 10.1038/nrclinonc.2014.111. Epub 2014 Jul 8. Nat Rev Clin Oncol. 2014. PMID: 25001465 Review.
Awareness and understanding of cancer immunotherapy in Europe.
Mellstedt H, Gaudernack G, Gerritsen WR, Huber C, Melero I, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C. Mellstedt H, et al. Among authors: gaudernack g. Hum Vaccin Immunother. 2014;10(7):1828-35. doi: 10.4161/hv.28943. Hum Vaccin Immunother. 2014. PMID: 25424789 Free PMC article.
Prospects for vaccine therapy for pancreatic cancer.
Gaudernack G. Gaudernack G. Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):299-314. doi: 10.1016/j.bpg.2006.01.003. Best Pract Res Clin Gastroenterol. 2006. PMID: 16549329 Review.
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials.
Ellingsen EB, Aamdal E, Guren T, Lilleby W, Brunsvig PF, Mangsbo SM, Aamdal S, Hovig E, Mensali N, Gaudernack G, Inderberg EM. Ellingsen EB, et al. Among authors: gaudernack g. J Immunother Cancer. 2022 May;10(5):e004345. doi: 10.1136/jitc-2021-004345. J Immunother Cancer. 2022. PMID: 35613827 Free PMC article.
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Brunsvig PF, Aamdal S, Gjertsen MK, Kvalheim G, Markowski-Grimsrud CJ, Sve I, Dyrhaug M, Trachsel S, Møller M, Eriksen JA, Gaudernack G. Brunsvig PF, et al. Among authors: gaudernack g. Cancer Immunol Immunother. 2006 Dec;55(12):1553-64. doi: 10.1007/s00262-006-0145-7. Epub 2006 Feb 21. Cancer Immunol Immunother. 2006. PMID: 16491401 Free PMC article. Clinical Trial.
217 results